Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07342829 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Follow-up After MVA-BN Booster Vaccination

Study acronym: POQS-Boosted
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoint revised
    • Secondary endpoints revised (2)
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
POQS-Boosted is a prospective observational study during which individuals who received Booster vaccination against mpox with the MVA-BN vaccine will be invited to provide biological samples at multiple times over the course of two years.
Trial Details
NCT Number NCT07342829
Lead Sponsor Institute of Tropical Medicine, Belgium
Conditions
(from sponsor)
Monkeypox (Mpox)
Related terms Mpox, Monkeypox
Enrollment 95 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov